Skip to main content
. 2023 Oct 18;45(2):2267138. doi: 10.1080/0886022X.2023.2267138

Figure 2.

Figure 2.

(A) Kaplan-Meier curve displayed the prognosis of the IgAN-NS and IgAN-NR cohorts (p = .3 [Log-rank test]). (B) Kaplan–Meier curve displayed the prognosis of the IgAN-NS and IgAN-NR without CR (p = .04 [log-rank]). The endpoint was defined as either a reduction of ≥30% in baseline eGFR or the development of ESRD. CR: complete remission of proteinuria; IgAN-NS: the IgAN with NS; IgAN-NR: the IgAN with nephrotic-range proteinuria.